Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar;34(3):523-529.
doi: 10.1038/s41433-019-0516-x. Epub 2019 Jul 29.

Progression and new onset of macular retinoschisis in myopic choroidal neovascularization eyes after Conbercept therapy: a post-hoc analysis

Affiliations
Randomized Controlled Trial

Progression and new onset of macular retinoschisis in myopic choroidal neovascularization eyes after Conbercept therapy: a post-hoc analysis

Yanping Zhou et al. Eye (Lond). 2020 Mar.

Abstract

Objectives: The objective of this study is to evaluate the progression and new onset of macular retinoschisis (MRS) in the patients treated with intravitreal Conbercept injections for myopic choroidal neovascularization (mCNV).

Methods: Post-hoc analysis of 160 mCNV patients included in SHINY study was performed to evaluate the impact of Conbercept injection on MRS in patients with mCNV undergoing intravitreal Conbercept injections. The patients were 3:1 randomized to the study group (three loading dose and thereafter pro re nata [PRN]) and the control group (3 months' sham injection, then one Conbercept injection at month 4 and thereafter PRN). MRS was assessed with optical coherence tomography by masked graders.

Results: At baseline, 28 of 122 eyes in study group and 10 of 38 eyes in control group had MRS. At month 3, two patients showed MRS progression and one patient had new onset MRS in study group. No MRS progression nor new onset MRS was found in the control group. At final visit, the cumulative incidence of MRS was 1.3% (2/160). Both Spearman's correlation and multiple logistic regression demonstrated no association between the progression and new onset of MRS and intravitreal injection frequency (correlation coefficient = 0.017, P = 0.851 and odds ratio = 0.996, P = 0.982). In addition, baseline vitreoretinal adhesion was the most likely potential risk factor resulting in MRS progression (odds ratio = 4.566, P = 0.027). Furthermore, MRS progression was more likely to take place in outer retinal layers.

Conclusions: The progression and new onset of MRS was not associated with the frequency of intravitreal Conbercept injections.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Representative case of MRS progression. a and d indicated the scanning position of macula. b and e demonstrated the baseline image of optical coherence tomography in myopic choroidal neovascularization eyes coexisted with retinoschisis. c and f showed an enlargement of macular retinoschisis toward new area at final visit. Vitreoretinal adhesion was referred to a visible high reflection at the interface between vitreous and retina without obvious traction (white arrows)

References

    1. Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology. 2006;113:1134 e1131–11. - PubMed
    1. Xu L, Li J, Cui T, Hu A, Fan G, Zhang R, et al. Refractive error in urban and rural adult Chinese in Beijing. Ophthalmology. 2005;112:1676–83. doi: 10.1016/j.ophtha.2005.05.015. - DOI - PubMed
    1. Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157:9–25. doi: 10.1016/j.ajo.2013.08.010. - DOI - PubMed
    1. Fujimoto M, Hangai M, Suda K, Yoshimura N. Features associated with foveal retinal detachment in myopic macular retinoschisis. Am J Ophthalmol. 2010;150:863–70. doi: 10.1016/j.ajo.2010.06.023. - DOI - PubMed
    1. Sayanagi K, Ikuno Y, Tano Y. Tractional internal limiting membrane detachment in highly myopic eyes. Am J Ophthalmol. 2006;142:850–2. doi: 10.1016/j.ajo.2006.05.031. - DOI - PubMed

Publication types

MeSH terms